GlassScriptPhysician profile
Javier Andre Otero
NPI 1922590520
$2,412.40
in general payments reported to CMS, 2019-2025
19 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.51 · 2022: $1,557 · 2023: $598 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $644.32 | 2022 | |
| Biogen, INC. | $485.81 | 2022-2025 | Vumerity, Spinraza |
| Horizon Therapeutics Plc | $177.48 | 2022 | |
| Emd Serono, INC. | $155.21 | 2023 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $137.66 | 2022 | |
| Genzyme Corporation | $114.90 | 2022 | |
| Ucb, INC. | $100.00 | 2022 | |
| Jazz Pharmaceuticals INC. | $100.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $88.59 | 2022-2023 | |
| Genentech USA, INC. | $79.92 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Amneal Pharmaceuticals LLC | $78.28 | 2022-2025 | Crexont |
| Abbvie INC. | $55.98 | 2023 | |
| Pbg Puerto Rico LLC | $40.70 | 2023-2025 | |
| Argenx US, INC. | $32.30 | 2025 | Vyvgart Hytrulo |
| E.R. Squibb & Sons, L.L.C. | $31.10 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $28.25 | 2022 | |
| Lundbeck LLC | $23.69 | 2023 | Vyepti |
| Banner Life Sciences, LLC | $22.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Otero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.